Why is Jenburkt Pharma falling/rising?

As of 10-Jul, Jenburkt Pharmaceuticals Ltd. is experiencing a price increase, currently at Rs 1,387.00, which reflects a rise of 15.0 points or 1.09%. The stock has shown strong performance, gaining 1.65% over the last two days and outperforming its sector by the same margin today. It opened with a gain of 2.04% and reached an intraday high of Rs 1,400. The stock has consistently outperformed the benchmark indices, with a remarkable 55.11% return over the past year and a staggering 166.76% over the last three years. Additionally, the company maintains a low debt-to-equity ratio, which supports its financial stability and attractiveness to investors.
In the broader market context, Jenburkt Pharmaceuticals has outperformed the Sensex, which has shown a slight decline of 0.06% over the past week, while Jenburkt's stock increased by 2.00%. The company's strong performance in both the short and long term, coupled with rising investor participation and liquidity, indicates a positive sentiment among investors. This favorable outlook is further supported by the stock's position above its moving averages, suggesting a bullish trend. Overall, the combination of solid returns, low debt levels, and positive market sentiment contributes to the stock's rising price.